Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia 22Burkitt Lymphoma 17Central Nervous System Neoplasms 15Neuroblastoma 13Lymphoma, Large B-Cell, Diffuse 13Sarcoma 11Lymphoma, Follicular 11Hodgkin Disease 10Brain Neoplasms 10Medulloblastoma 9Rhabdomyosarcoma 8Wilms Tumor 7Leukemia, Biphenotypic, Acute 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Large-Cell, Anaplastic 6Oligodendroglioma 5Lymphoma, Mantle-Cell 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Multiple Myeloma 4Malignant mesenchymal tumor 4Dendritic Cell Sarcoma, Interdigitating 4Astrocytoma 4Waldenstrom Macroglobulinemia 3Sarcoma, Ewing 3Rhabdoid Tumor 3Lymphoma, Large-Cell, Immunoblastic 3Ganglioneuroblastoma 3

Interventions

Paclitaxel 4Taxes 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Mental Status and Dementia Tests 2Cisplatin 2Amifostine 2Vincristine 1Temozolomide 1Rituximab 1Procarbazine 1Methotrexate 1Memantine 1Magnetic Resonance Spectroscopy 1Diffusion Tensor Imaging 1Cytarabine 1Carboplatin 1Brachytherapy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neurotoxicity Syndromes × Vincristine × Clear all
NCT01399372 2023-07-20

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Radiation Therapy Oncology Group

Phase 2 Completed
91 enrolled 17 charts
Lymphoid

Lymphoma, Radiation Injuries, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡